A cross-sectional analysis of the relationship between uric acid and coronary atherosclerosis in patients with suspected coronary artery disease in China

BMC Cardiovascular Disorders

Volumn 14, Issue 1, 2014, Pages

  Sun, Yujiao ^a   Yu, Xin ^a   Zhi, Ying ^a   Geng, Song ^a   Li, Hua ^a   Liu, Ting ^a   Xu, Ke ^a   Chen, Ling ^a   Wu, Chunwei ^a   Qi, Guoxian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Calcium score; Coronary atherosclerosis; Coronary computed tomography angiography; Gender; Uric acid

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPERGLYCEMIC AGENT; INSULIN; METOPROLOL; URIC ACID; BIOLOGICAL MARKER;

ADULT; ARTICLE; CHINA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIUM SCORE; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; IMAGE ANALYSIS; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; AGED; ANGIOCARDIOGRAPHY; ATHEROSCLEROTIC PLAQUE; BLOOD; CHI SQUARE DISTRIBUTION; CORONARY STENOSIS; DISEASE COURSE; EPIDEMIOLOGY; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIVARIATE ANALYSIS; PROCEDURES; RISK; SEX DIFFERENCE; STATISTICAL MODEL; VASCULAR CALCIFICATION;

AGED; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CHINA; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY STENOSIS; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIVARIATE ANALYSIS; ODDS RATIO; PLAQUE, ATHEROSCLEROTIC; PREVALENCE; RISK FACTORS; SEX FACTORS; URIC ACID; VASCULAR CALCIFICATION;

EID: 84906824415     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-14-101     Document Type: Article

References (43)

1. Saugstad OD. Role of xanthine oxidase and its inhibitor in hypoxia: reoxygenation injury. Pediatrics 1996, 98:103-107.
2. Lee J, Sparrow D, Vokonas PS, Landsberg L, Weiss ST. Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome: the normative aging study. Am J Epidemiol 1995, 142:288-294.
3. Puig JG, Micha´n AD, Jime´nez ML, Pe´rez De Ayala C, Mateos FA, Capita´n CF, De Miguel E, Gijo´n JB. Female gout: clinical spectrum and uric acid metabolism. Arch Intern Med 1991, 151:726-732. 10.1001/archinte.1991.00400040074016, 2012455.
4. Puig JG, Ruilope LM. Uric acid as a cardiovascular risk factor in arterial hypertension. J Hypertens 1999, 17:869-872. 10.1097/00004872-199917070-00001, 10419058.
5. Chu NF, Wang DJ, Liou SH, Shieh SM. Relationship between hyperuricemia and other cardiovascular disease risk factors among adult males in Taiwan. Eur J Epidemiol 2000, 16:13-17. 10.1023/A:1007654507054, 10780337.
6. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2010, 62:170-180. 3156692, 20191515.
7. Yildiz A, Kaya Z. A crucial marker of cardiovascular diseases?. Int J Cardiol 2012, 159:158. 10.1016/j.ijcard.2012.05.054, 22658353.
8. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham heart study. Ann Intern Med 1999, 131:7-13. 10.7326/0003-4819-131-1-199907060-00003, 10391820.
9. Dutta A, Henley W, Pilling LC, Wallace RB, Melzer D. Uric acid measurement improves prediction of cardiovascular mortality in later life. J Am Geriatr Soc 2013, 61:319-326. 10.1111/jgs.12149, 23496291.
10. Niskanen LK, Laaksonen DE, Nyyssonen K, Alfthan G, Lakka HM, Lakka TA. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004, 164:1546-1551. 10.1001/archinte.164.14.1546, 15277287.
11. Davies KJ, Sevanian A, Muakkassah-Kelly SF, Hochstein P. Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem J 1986, 235:747-754. 1146751, 3753442.
12. Hoieggen A, Alderman MH, Kjeldsen SE, Julius S, Devereux RB, De Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Chen C, Dahlo¨f B, . LIFE Study Group LIFE study group. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int 2004, 65:1041-1049. 10.1111/j.1523-1755.2004.00484.x, 14871425, LIFE Study Group.
13. Ndrepepa G, Braun S, King L, Fusaro M, Tada T, Cassese S, Hadamitzky M, Haase HU, Scho¨mig A, Kastrati A. Uric acid and prognosis in angiography-proven coronary artery disease. Eur J Clin Invest 2013, 43:256-266. 10.1111/eci.12039, 23278454.
14. Sinan Deveci O, Kabakci G, Okutucu S, Tulumen E, Aksoy H, Baris Kaya E, Evranos B, Aytemir K, Tokgozoglu L, Oto A. The association between serum uric acid level and coronary artery disease. Int J Clin Pract 2010, 64:900-907. 10.1111/j.1742-1241.2009.02263.x, 20584223.
15. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990, 15:827-832. 10.1016/0735-1097(90)90282-T, 2407762.
16. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, McGoon DC, Murphy ML, Roe BB. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc committee for grading of coronary artery disease, council on cardiovascular surgery. American heart association. Circulation 1975, 51(suppl):5-40.
17. Cheng VY, Wolak A, Gutstein A, Gransar H, Wong ND, Dey D, Thomson LE, Hayes SW, Friedman JD, Slomka PJ, Berman DS. Low-density lipoprotein and noncalcified coronary plaque composition in patients with newly diagnosed coronary artery disease on computed tomographic angiography. Am J Cardiol 2010, 105:761-766. 10.1016/j.amjcard.2009.11.007, 20211316.
18. Abada HT, Larchez C, Daoud B, Sigal-Cinqualbre A, Paul JF. MDCT of the coronary arteries: feasibility of low-dose CT with ECG-pulsed tube current modulation to reduce radiation dose. Am J Roentgenl 2006, 186:S387-S390.
19. Mark DB, Berman DS, Budoff MJ, Carr JJ, Gerber TC, Hecht HS, Hlatky MA, Hodgson JM, Lauer MS, Miller JM, Morin RL, Mukherjee D, Poon M, Rubin GD, Schwartz RS. ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT2010 expert consensus document on coronary computed tomographic angiography: a report of the American college of cardiology foundation task force on expert consensus documents. Circulation 2010, 121:2509-2543.
20. Kocaman SA, Sahinarslan A, Cemri M, Timurkaynak T, Boyaci B, Cengel A. Independent relationship of serum uric acid levels with leukocytes and coronary atheroscleroticburden. Nutr Metab Cardiovasc Dis 2009, 19:729-735. 10.1016/j.numecd.2008.12.010, 19699626.
21. Ioachimescu AG, Brennan DM, Hoar BM, Hazen SL, Hoogwerf BJ. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study. Arthritis Rheum 2008, 58:623-630. 10.1002/art.23121, 18240236.
22. Moriarity JT, Folsom AR, Iribarren C, Nieto FJ, Rosamond WD. Serum acid uric and risk of coronary heart disease: atherosclerosis risk in communities (ARIC) study. Ann Epidemiol 2000, 10:136-143.
23. Strasak A, Ruttmann E, Brant L, Kelleher C, Klenk J, Concin H, Diem G, Pfeiffer K, Ulmer H, . VHM&PP Study Group Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men. Clin Chem 2008, 54:273-284. 10.1373/clinchem.2007.094425, 18039719, VHM&PP Study Group.
24. Tavil Y, Kaya MG, Oktar SO, Sen N, Okyay K, Yazici HU, Cengel A. Uric acid level and its association with carotid intima-media thickness in patients with hypertension. Atherosclerosis 2008, 197:159-163. 10.1016/j.atherosclerosis.2007.03.008, 17416371.
25. Mutluay R, Deger SM, Bahadir E, Durmaz AO, Citil R, Sindel S. Uric acid is an important predictor for hypertensive early atherosclerosis. Adv Ther 2012, 29:276-286. 10.1007/s12325-012-0006-z, 22392103.
26. Cipolli JA, Ferreira-Sae MC, Martins RP, Pio-Magalhães JA, Bellinazzi VR, Matos-Souza JR, Junior WN. Relationship between serum uric acid and internal carotid resistive index in hypertensive women: a cross-sectional study. BMC Cardiovasc Disord 2012, 12:52. 10.1186/1471-2261-12-52, 3418193, 22800461.
27. Liese AD, Hense HW, Lo¨wel H, Do¨ring A, Tietze M, Keil U. Association of serum uric acid with all-cause and cardiovascular disease mortality and inci-dent myocardial infarction in the MONICA Augsburg cohort world health organization monitoring trends and determinants in cardiovascular diseases. Epidemiology 1999, 10:391-397. 10.1097/00001648-199907000-00009, 10401873.
28. Fang J, Alderman MH. Serum uric acid and cardiovascular mortal-ity the NHANES I epidemiologic follow-up study, 1971-1992 national health and nutrition examination survey. JAMA 2000, 283:2404-2410. 10.1001/jama.283.18.2404, 10815083.
29. Tuttle KR, Short RA, Johnson RJ. Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol 2001, 87:1411-1414. 10.1016/S0002-9149(01)01566-1, 11397367.
30. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, Liu K, Shea S, Szklo M, Bluemke DA, O'Leary DH, Tracy R, Watson K, Wong ND, Kronmal RA. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008, 358:1336-1345. 10.1056/NEJMoa072100, 18367736.
31. Pletcher MJ, Tice JA, Pignone M. Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Arch Internmed 2004, 164:1285-1292.
32. Rodrigues TC, Maahs DM, Johnson RJ, Jalal DI, Kinney GL, Rivard C, Rewers M, Snell-Bergeon JK. Serum uric acid predicts progression of subclinical coronary atherosclerosis in individuals without renal disease. Diabetes Care 2010, 33:2471-2473. 10.2337/dc10-1007, 2963516, 20798338.
33. Mitsutake R, Miura S, Saku K. Association between coronary artery calcification score as assessed by multi-detector row computed tomography and upstroke time of pulse wave. Intern Med 2007, 46:1833-1836. 10.2169/internalmedicine.46.0321, 18025764.
34. Coutinho Tde A, Turner ST, Peyser PA, Bielak LF, Sheedy PF, Kullo IJ. Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis. Am J Hypertens 2007, 20:83-89. 10.1016/j.amjhyper.2006.06.015, 17198917.
35. Atar AI, Yilmaz OC, Akin K, Selcoki Y, Er O, Eryonucu B. Association between gamma-glutamyltransferase and coronary artery calcification. Int J Cardiol 2012, Epub ahead of print.
36. Kaya EB, Yorgun H, Canpolat U, Hazi{dotless}rolan T, Sunman H, U¨lgen A, Ates AH, Aytemir K, Tokgo¨zogˇlu L, Kabakci{dotless} G, Akata D, Oto A. Serum uric acid levels predict the severity and morphology of coronary atherosclerosis detected by multidetector computed tomography. Atherosclerosis 2010, 213:178-183. 10.1016/j.atherosclerosis.2010.08.077, 20863499.
37. Sano K, Kawasaki M, Ishihara Y, Okubo M, Tsuchiya K, Nishigaki K, Zhou X, Minatoguchi S, Fujita H, Fujiwara H. Assessment of vulnerable plaques causing acute coronary syndrome using integrated backscatter intravascular ultrasound. J Am Coll Cardiol 2006, 47:734-741. 10.1016/j.jacc.2005.09.061, 16487837.
38. Pundziute G, Schuijf JD, Jukema JW, Decramer I, Sarno G, Vanhoenacker PK, Boersma E, Reiber JH, Schalij MJ, Wijns W, Bax JJ. Evaluation of plaque characteristics in acute coronary syndrome: non-invasive assessment with multi-slice computed tomography and invasive evaluation with intravascular ultrasound radiofrequency data analysis. Eur Heart J 2008, 29:2373-2381. 10.1093/eurheartj/ehn356, 18682447.
39. Gagliardi AC, Miname MH, Santos RD. Uric acid: a marker of increased cardiovascular risk. Atherosclerosis 2009, 202:11-17. 10.1016/j.atherosclerosis.2008.05.022, 18585721.
40. Yildiz A, Yilmaz R, Demirbag R, Gur M, Bas MM, Erel O. Association of serum uric acid level and coronary blood flow. Coron Artery Dis 2007, 18:607-613. 10.1097/MCA.0b013e3282f0a2a7, 18004110.
41. Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, Wamsley A, Sheikh-Hamad D, Lan HY, Feng L, Johnson RJ. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003, 41:1287-1293. 10.1161/01.HYP.0000072820.07472.3B, 12743010.
42. Kuwahata S, Hamasaki S, Ishida S, Kataoka T, Yoshikawa A, Orihara K, Ogawa M, Oketani N, Saihara K, Okui H, Shinsato T, Kubozono T, Ichiki H, Fujita S, Takumi T, Yoshino S, Nakazaki M, Miyata M, Tei C. Effect of uric acid on coronary microvascular endothelial function in women: association with eGFR and ADMA. J Atheroscler Thromb 2010, 17:259-269. 10.5551/jat.1594, 20228613.
43. Athyros VG, Mikhailidis DP, Liberopoulos EN, Kakafika AI, Karagiannis A, Papageorgiou AA, Tziomalos K, Ganotakis ES, Elisaf M. Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study. Nephrol Dial Transplant 2007, 22:118-127.